Triethylamine → (3S,4S)-3-[3-(4-methanesulfonyl-benzyl)-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-8-ylmethyl]-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester

HRID 2234209ノート

反応式

HRID 2234209 の反応式
Cl.[CH3:2][S:3]([C:6]1[CH:24]=[CH:23][C:9]([CH2:10][N:11]2[C:15](=[O:16])[C:14]3([CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)[NH:13][C:12]2=[O:22])=[CH:8][CH:7]=1)(=[O:5])=[O:4].C(N(CC)CC)C.[C:32]([O:36][C:37]([N:39]1[CH2:43][C@H:42]([C:44]2[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=2)[C@@H:41]([CH:50]=O)[CH2:40]1)=[O:38])([CH3:35])([CH3:34])[CH3:33].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C(Cl)Cl>[C:32]([O:36][C:37]([N:39]1[CH2:43][C@H:42]([C:44]2[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=2)[C@@H:41]([CH2:50][N:19]2[CH2:18][CH2:17][C:14]3([NH:13][C:12](=[O:22])[N:11]([CH2:10][C:9]4[CH:8]=[CH:7][C:6]([S:3]([CH3:2])(=[O:5])=[O:4])=[CH:24][CH:23]=4)[C:15]3=[O:16])[CH2:21][CH2:20]2)[CH2:40]1)=[O:38])([CH3:35])([CH3:33])[CH3:34]

参加物

6

反応物 4

HCID 8471TriethylamineHCID 5049666Sodium triacetoxyborohydrideHCID 58981949(3R,4S)-3-formyl-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl esterHCID 686263323-(4-Methanesulfonyl-benzyl)-1,3,8-triaza-spiro[4.5]decane-2,4-dione hydrochloride

生成物 1

HCID 11628596(3S,4S)-3-[3-(4-methanesulfonyl-benzyl)-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-8-ylmethyl]-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester収率 31%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

To 187 mg (0.50 mmol) of 3-(4-methanesulfonyl-benzyl)-1,3,8-triaza-spiro[4.5]decane-2,4-dione hydrochloride was added 5 mL of DCM followed by 0.066 mL of triethylamine (0.50 mmol) and a solution of (3R,4S)-3-formyl-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester (0.93 mL of a 148 mg/mL solution, 0.50 mmol). The solution was stirred at room temperature for 30 minutes and sodium triacetoxyborohydride was added (159 mg, 0.75 mmol). The solution was stirred overnight. The resulting mixture was evaporated to dryness and purified by chromatography on Bond Elute™ (10 g) using 1:1 EtOAc:Hexane followed by 1% methanol in DCM. After evaporation of the desired fractions, 93 mg (31%) of (3S,4S)-3-[3-(4-methanesulfonyl-benzyl)-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-8-ylmethyl]-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester as a white solid were obtained.

後処理

  1. stirringThe solution was stirred overnight
  2. customThe resulting mixture was evaporated to dryness
  3. custompurified by chromatography on Bond
  4. washElute™ (10 g)
  5. customAfter evaporation of the desired fractions

出典と根拠

ORDレコード
ord-a3ae5914ae214f3ebe93869984b9ac6e
出典データセット
uspto-grants-2010_05
特許番号
US07709642B2

反応ノート

読み込み中…